User Generated >>
GlaxoSmithKline SWOT Analysis:
|
Strengths [list]
[*]Reputation management on RD and Production only [*]sound capital base [*]good infrastructure [*]large market share [*]large highly skilled work force [*]wide range of products and mix edge drugs down to toothpaste Globally positioned in the pharmaceutical industry [*] |
Weaknesses [list]
[*]Low market dominance [*]No online presence [*]Inconsistency of attractive promotions [*]High dependancy on only several products [*]Rahul gupta as marketing rep. Tom is a tit weknesss is wekness, power is power |
|
Opportunities [list]
[*]Emerging markets and expansion abroad [*]Developing vaccines for persistent diseases Chance to have the craic ***IES |
Threats [list]
[*]Lower cost competitors or imports [*]counterfeit drugs being sold in competition with legitimate products [*]political pressure to sell at prices that fail to pay for the development of new drugs or to recover past development costs [*]patent expiry on drugs that generate strong income [*]increasing cost of drug trials (research) and ever higher standards imposed by national drug approvals bodies online presence of compitetors high delivery ratio of competitors |
History: Version 20 (Newest), Version 19, Version 18, Version 17, Version 16, Version 15, Version 14, Version 13, Version 12, Version 11, Version 10, Version 9, Version 8, Version 7, Version 6, Version 5, Version 4, Version 3, Version 2, Version 1 (Oldest)
Go back to the SWOT analysis index, or start a discussion about GlaxoSmithKline SWOT analysis by adding a comment below